NovoCure Ltd (NVCR) stock, explained like you're 5

Is NovoCure Ltd a small, medium or large cap company?

No. NovoCure Ltd is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.7 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How NovoCure Ltd makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves NVCR stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• NovoCure (NVCR) Breaks Out on Q2 2026 Earnings Optune Pax Driving Recovery (TradingKey)
• NVCR Rallies On FDA Approval For Cancer Treatment Device, Analyst Still Sees 275% Potential Upside (Stocktwits)
• NovoCure: A Mispriced Cash Generating Biotech With Upside Potential (NASDAQ:NVCR) (Seeking Alpha)
• NovoCure (NVCR) Stock News & Updates (Stock Titan)
• Novocure (NVCR) Hits New High on Optimistic Outlook, FDA Approval Hopes (Yahoo Finance)

Key terms to know before you follow NVCR

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility